Alberta Investment Management Corp (AIMCo)’s Acceleron Pharma XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-28,800
Closed -$4.97M – 1196
2021
Q3
$4.97M Buy
+28,800
New +$3.77M 0.04% 427
2017
Q1
– Sell
-49,460
Closed -$1.26M – 951
2016
Q4
$1.26M Buy
+49,460
New +$1.57M 0.01% 519

Alberta Investment Management Corp (AIMCo)'s XLRN Position: Q4 2021 in Review

Alberta Investment Management Corp (AIMCo) sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 28,800 shares — an estimated $4.97M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in XLRN in Q4 2016 and held it in 2 quarters. The position peaked at $4.97M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 28,800 Acceleron Pharma shares in Q4 2021, an estimated $4.97M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Acceleron Pharma in Q4 2016 and held it in 2 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Acceleron Pharma position peaked at $4.97M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q4 2021, filed 11 Feb 2022.